|
Increased need for Pharmaceutical Companies to Outsource Marketing, Regulatory and Downstream Services.
(PRWEB) October 9, 2004 -- Research and Markets announces the addition of the "BioMed Outsourcing Report - Opportunities in Outsourcing Marketing, Regulatory and Downstream Services" to its offering.
This report highlights key issues facing the bio-pharmaceutical industry with regard to outsourcing marketing, public relations, branding, regulatory affairs, regulatory submissions including electronic submissions, medical writing and editing, sales, marketing and clinical research staff recruitment, and validation and quality control services.
Also included is a directory featuring North American regulatory affairs service providers.
Topics covered include:
- Partnerships to Manage the Product Launch
- The Role of Branding in the Pharmaceutical Industry
- Building Effective Relationships with Patient Advocacy Groups
- Outsourcing to Regulatory Affairs Professionals to Manage Global Approvals
- Regulatory Submissions and Global Harmonization
- Fulfilling the Need for Objective Medical Writing and Editing in Scientific Communications
- Identifying the Best Candidates for Sales, Marketing and Clinical Research
- Outsourcing Validation and Quality Control Services
- Directory of North American Regulatory Affairs Service Providers
For a complete index of this report click on http://www.researchandmarkets.com/reports/220913
About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.
For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com
|
